Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma 		0.300 Biomarker disease CTD_human Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS. 21472284 2012
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder) 		0.300 Biomarker disease CTD_human Comparative proteome analysis of human adenocarcinoma. 19381893 2010
CUI: C0011570
Disease: Mental Depression
Mental Depression 		0.200 Therapeutic disease RGD Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. 25641667 2015
CUI: C0010308
Disease: Congenital Hypothyroidism
Congenital Hypothyroidism 		0.200 Biomarker disease RGD [Proteomic changes in cerebral cortex of neonatal rats with experimental congenital hypothyroidism]. 21575372 2011
CUI: C0342200
Disease: Endemic Cretinism
Endemic Cretinism 		0.200 Biomarker disease RGD [Proteomic changes in cerebral cortex of neonatal rats with experimental congenital hypothyroidism]. 21575372 2011
CUI: C0011853
Disease: Diabetes Mellitus, Experimental
Diabetes Mellitus, Experimental 		0.200 Biomarker disease RGD Differences in expression of retinal proteins between diabetic and normal rats. 17465459 2007
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor 		0.010 AlteredExpression disease BEFREE Chromophobes express proteins associated with ATP function (ATP5I & 5E; VATE1 & G2; ADT2), glycolysis (PGK1) and neuromedin whilst oncocytomas express ATP5H, ATPA, DEPD7 and TRIPB thyroid receptor interacting protein. 31514886 2020
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.010 Biomarker group BEFREE ATP5H loss in the tumor is strongly linked to failure of therapy, disease progression, and poor survival in patients with cancer. 30124467 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.010 Biomarker group BEFREE ATP5H loss in the tumor is strongly linked to failure of therapy, disease progression, and poor survival in patients with cancer. 30124467 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm 		0.010 Biomarker group BEFREE ATP5H loss in the tumor is strongly linked to failure of therapy, disease progression, and poor survival in patients with cancer. 30124467 2018
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease 		0.010 GeneticVariation disease BEFREE We identified a novel association with AD in the adenosine triphosphate (ATP) synthase, H+ transporting, mitochondrial F0 (ATP5H)/Potassium channel tetramerization domain-containing protein 2 (KCTD2) locus, which reached genome-wide significance in the combined discovery and genotyping sample (rs11870474, odds ratio (OR)=1.58, P=2.6 × 10(-7) in discovery and OR=1.43, P=0.004 in Fundació ACE data set; combined OR=1.53, P=4.7 × 10(-9)). 23857120 2014
CUI: C0036341
Disease: Schizophrenia
Schizophrenia 		0.010 AlteredExpression disease LHGDN Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. 19110265 2009